rtcgm dexcom g4 with 505 software (Dexcom Inc)
90
Structured Review
Dexcom Inc
rtcgm dexcom g4 with 505 software
Rtcgm Dexcom G4 With 505 Software, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rtcgm+(g4+software+505/g4+505+share+ap+system/pmc07957379-106-10-11
Average 90 stars, based on 1 article reviews
Rtcgm Dexcom G4 With 505 Software, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rtcgm+(g4+software+505/g4+505+share+ap+system/pmc07957379-106-10-11
Average 90 stars, based on 1 article reviews
rtcgm dexcom g4 with 505 software - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring"
Article Title: Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring
Journal: Diabetes Technology & Therapeutics
doi: 10.1089/dia.2021.0007
Figure Legend Snippet: Real-Time Continuous Glucose Monitoring Trials in Patients with Type 2 Diabetes
Techniques Used: Modification, Control
Figure Legend Snippet: Professional Society Recommendations for Continuous Glucose Monitoring Use in the Management of Type 2 Diabetes
Techniques Used:
Related Articles
other:Article Title: Mitigation of Rebound Hyperglycemia With Real-Time Continuous Glucose Monitoring Data and Predictive Alerts Article Snippet: Data were collected from a four-week pre-randomization phase in which Article Title: Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring Article Snippet: Earlier systematic reviews and meta-analyses of CGM studies (including both rtCGM and professional CGM) suggested benefits of CGM in improving glycemic control, especially in insulin-treated patients with T2D., The DiaMonD (Multiple Daily Injections and CGM in Diabetes ) trial was a larger study that randomized 158 individuals with T2D using multiple daily insulin (MDI) to either Article Title: Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring Article Snippet: In a study by Beck et al., the use of rtCGM ( Article Title: Mitigation of Rebound Hyperglycemia With Real-Time Continuous Glucose Monitoring Data and Predictive Alerts. Article Snippet: Data were collected from a four-week pre-randomization phase in which Software:Article Title: Replacement of Blood Glucose Measurements by Measurements With Systems for Real-Time Continuous Glucose Monitoring (rtCGM) or CGM With Intermittent Scanning (iscCGM): A German View Article Snippet: .. 04/2014): - In phases of rapidly changing glucose values - To confirm a sensor-reported hypoglycemia or impending hypoglycemia - If symptoms do not comply with the glucose value displayed by the system In the DIAMOND study, in which the Article Title: Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial Article Snippet: Methods The HypoDE study was a 6-month, multicentre, open-label, parallel, randomised controlled trial done at 12 diabetes practices in Germany.. Eligible participants had type 1 diabetes and a history of impaired hypoglycaemia awareness or severe hypoglycaemia during the previous year.. All participants wore a masked rtCGM system for 28 days and were then randomly assigned to 26 weeks of unmasked rtCGM (Dexcom G5 Mobile system) or to the control group (continuing with self-monitoring of blood glucose). |